Molecular Diagnostics Technologies Market is anticipated to surpass US$33.5 billion in 2031 at a CAGR of 8.9%

According to a research study published by Knowledge Sourcing Intelligence (KSI), the molecular diagnostics technologies market will expand from USD 21.9 billion in 2026 to USD 33.5 billion in 2031 at a CAGR of 8.9% during the forecast period.

The molecular diagnostics technologies market will experience consistent expansion because there is a growing requirement for diagnostic solutions that provide both speed and precision, and because genomic technology continues to progress.

Access sample report or view details: https://www.knowledge-sourcing.com/report/molecular-diagnostics-technologies-market

Key Market Insight & Emerging Trends:

The healthcare sector is expanding its molecular diagnostic technologies market because of the rising demand for early disease detection, precision medicine, and personalized treatment methods. The market experiences growth because of increasing infectious disease and cancer cases, together with rising public awareness about genetic testing.

Next-generation sequencing (NGS) and real-time PCR technologies enable more accurate diagnoses, which require less time for results. The healthcare industry benefits from two trends, which are the rising use of point-of-care molecular diagnostics and laboratory automation systems.

The market growth accelerates because government programs support genomic research, while molecular diagnostics become integrated into standard clinical operations. The healthcare systems of emerging Asian economies experience rapid development because of their upgraded medical facilities and higher health expenditure.

• North America maintained its market leadership during 2025 because of its advanced laboratory systems and the presence of major industry players.

• The market by product type shows reagents and kits as the leading product category because these items are used by doctors for their diagnostic tests.

• PCR technology remains the leading market solution because of its extensive use and ability to identify pathogens with high accuracy.

• The application of infectious diseases accounts for a major market share because of the requirement for fast disease identification and effective epidemic response.

The market for molecular diagnostic technologies operates with high competition because top companies emphasize both product innovation and the development of new products, and the formation of business partnerships.

Product Insights: Reagents & Kits Segment Leading Demand

The reagents and kits segment held the highest market share during 2025 because diagnostic tests require their products to be used continuously. The rising demand for testing infectious diseases and genetic disorders leads to an ongoing need for superior reagents and assay kits.

Technology Insights: PCR as the Major Technology

The market continues to depend on Polymerase Chain Reaction (PCR) technology because it delivers accurate results with high sensitivity and produces results at a fast rate. The technology acts as the main solution for various fields that include detecting infectious diseases and conducting genetic studies.

Application Insights: Infectious Diseases Driving Market Growth

The molecular diagnostics technologies market enables swift pathogen detection, which helps medical professionals to handle disease outbreaks effectively. The increasing global outbreaks of new infectious diseases and the need for fast diagnostic tests will create new business opportunities.

Regional Highlights: North America Dominance with Rapid Asia Pacific Growth

North America preserved its top position in 2025 because its healthcare systems function effectively, its research and development funds grow, and its medical facilities use modern diagnostic tools. The Asia Pacific region will experience rapid development during the forecast period because healthcare access expands, the population grows, and governments increase their disease surveillance efforts.

Competitive Landscape

As a part of the report, the major players operating in the molecular diagnostics technologies market have been covered, such as Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Qiagen, Bio-Rad Laboratories, Hologic, Agilent Technologies, Illumina, and Siemens Healthineers. The major companies in this market strengthen their position through product development, technological progress, and expansion into new markets, while smaller companies and local businesses concentrate on affordable diagnostic products in specific markets.

Market Segmentation

The report segments the molecular diagnostics technologies market as follows:

• By Product Type

  • Instruments

  • Reagents & Kits

  • Software & Services

• By Technology

  • Polymerase Chain Reaction (PCR)

  • Next-Generation Sequencing (NGS)

  • In Situ Hybridization (ISH)

  • Microarrays

  • Isothermal Nucleic Acid Amplification

• By Application

  • Infectious Diseases

  • Oncology

  • Genetic Testing

  • Blood Screening

  • Transplant Diagnostics

• By Geography

  • North America

    • USA

    • Canada

    • Mexico

  • South America

    • Brazil

    • Argentina

    • Others

  • Europe

    • United Kingdom

    • Germany

    • France

    • Spain

    • Others

  • Middle East and Africa

    • Saudi Arabia

    • UAE

    • Others

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Indonesia

    • Thailand

    • Others

Companies Profiled:

• Roche Diagnostics

• Thermo Fisher Scientific

• Abbott Laboratories

• Danaher Corporation

• Qiagen

• Bio-Rad Laboratories

• Hologic

• Agilent Technologies

• Illumina

• Siemens Healthineers

Explore More Reports:

• Companion Diagnostics For Targeted Therapies Market

• Functional and Metabolic Imaging Diagnostics Market

• Microbiome Diagnostics and Analysis Market